United States Prostate Cancer Vaccine Industry 2016 Deep Market Research Report
- QYR525268
- 138 Pages
- March 2016
- Pharmaceuticals
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Prostate Cancer Vaccine market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Prostate Cancer Vaccine industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 152 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Industry Overview
1.1 Definition and Specifications of Prostate Cancer Vaccine
1.1.1 Definition of Prostate Cancer Vaccine
1.1.2 Specifications of Prostate Cancer Vaccine
1.2 Classification of Prostate Cancer Vaccine
1.3 Applications of Prostate Cancer Vaccine
1.4 Industry Chain Structure of Prostate Cancer Vaccine
1.5 Industry Overview of Prostate Cancer Vaccine
1.6 Industry Policy Analysis of Prostate Cancer Vaccine
1.7 Industry News Analysis of Prostate Cancer Vaccine
2 Manufacturing Cost Structure Analysis of Prostate Cancer Vaccine
2.1 Bill of Materials (BOM)of Prostate Cancer Vaccine
2.2 BOM Price Analysis of Prostate Cancer Vaccine
2.3 Labor Cost Analysis of Prostate Cancer Vaccine
2.4 Depreciation Cost Analysis of Prostate Cancer Vaccine
2.5 Manufacturing Cost Structure Analysis of Prostate Cancer Vaccine
2.6 Manufacturing Process Analysis of Prostate Cancer Vaccine
2.7 United States Price, Cost and Gross of Prostate Cancer Vaccine 2011-2016
3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015
3.2 Manufacturing Plants Distribution of United States Key Prostate Cancer Vaccine Manufacturers in 2015
3.3 R&D Status and Technology Source of United States Prostate Cancer Vaccine Key Manufacturers in 2015
3.4 Raw Materials Sources Analysis of United States Prostate Cancer Vaccine Key Manufacturers in 2015
4 Production Analysis of Prostate Cancer Vaccine by Regions, Type, and Applications
4.1 United States Production of Prostate Cancer Vaccine by Regions 2011-2016
4.2 United States Production of Prostate Cancer Vaccine by Type 2011-2016
4.3 United States Sales of Prostate Cancer Vaccine by Applications 2011-2016
4.4 Price Analysis of United States Prostate Cancer Vaccine Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Prostate Cancer Vaccine 2011-2016
5 Consumption Volume and Consumption Value Analysis of Prostate Cancer Vaccine by Regions
5.1 United States Consumption Volume of Prostate Cancer Vaccine by Regions 2011-2016
5.2 United States Consumption Value of Prostate Cancer Vaccine by Regions 2011-2016
5.3 United States Consumption Price Analysis of Prostate Cancer Vaccine by Regions 2011-2016
6 Analysis of Prostate Cancer Vaccine Production, Supply, Sales and Market Status 2011-2016
6.1 Capacity, Production, Sales, and Revenue of Prostate Cancer Vaccine 2011-2016
6.2 Production Market Share and Sales Market Share Analysis of Prostate Cancer Vaccine 2014-2015
6.3 Sales Overview of Prostate Cancer Vaccine 2011-2016
6.4 Supply, Consumption and Gap of Prostate Cancer Vaccine 2011-2016
6.5 Import, Export and Consumption of Prostate Cancer Vaccine 2011-2016
6.6 Cost, Price, Revenue and Gross Margin of Prostate Cancer Vaccine 2011-2016
7 Analysis of Prostate Cancer Vaccine Industry Key Manufacturers
7.1 Bellicum pharmaceuticals
7.1.1 Company Profile
7.1.2 Product Picture and Specifications
7.1.2.1 Type I
7.1.2.2 Type II
7.1.2.3 Type III
7.1.3 Capacity, Production, Price, Cost, Gross and Revenue
7.1.4 Contact Information
7.2 Adamis pharmaceuticals
7.2.1 Company Profile
7.2.2 Product Picture and Specifications
7.2.2.1 Type I
7.2.2.2 Type II
7.2.2.3 Type III
7.2.3 Capacity, Production, Price, Cost, Gross and Revenue
7.2.4 Contact Information
7.3 Aduro biotech
7.3.1 Company Profile
7.3.2 Product Picture and Specifications
7.3.2.1 Type I
7.3.2.2 Type II
7.3.2.3 Type III
7.3.3 Capacity, Production, Price, Cost, Gross and Revenue
7.3.4 Contact Information
7.4 Cytovac
7.4.1 Company Profile
7.4.2 Product Picture and Specifications
7.4.2.1 Type I
7.4.2.2 Type II
7.4.2.3 Type III
7.4.3 Capacity, Production, Price, Cost, Gross and Revenue
7.4.4 Contact Information
7.5 Immunovaccine
7.5.1 Company Profile
7.5.2 Product Picture and Specifications
7.5.2.1 Type I
7.5.2.2 Type II
7.5.2.3 Type III
7.5.3 Capacity, Production, Price, Cost, Gross and Revenue
7.5.4 Contact Information
7.6 Oncbiomune
7.6.1 Company Profile
7.6.2 Product Picture and Specifications
7.6.2.1 Type I
7.6.2.2 Type II
7.6.2.3 Type III
7.6.3 Capacity, Production, Price, Cost, Gross and Revenue
7.6.4 Contact Information
7.7 Dendreon
7.7.1 Company Profile
7.7.2 Product Picture and Specifications
7.7.2.1 Type I
7.7.2.2 Type II
7.7.2.3 Type III
7.7.3 Capacity, Production, Price, Cost, Gross and Revenue
7.7.4 Contact Information
7.8 Sotio
7.8.1 Company Profile
7.8.2 Product Picture and Specifications
7.8.2.1 Type I
7.8.2.2 Type II
7.8.2.3 Type III
7.8.3 Capacity, Production, Price, Cost, Gross and Revenue
7.8.4 Contact Information
8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Prostate Cancer Vaccine Product Types
8.5 Market Share Analysis of Different Prostate Cancer Vaccine Price Levels
8.6 Gross Margin Analysis of Different Prostate Cancer Vaccine Applications
9 Marketing Trader or Distributor Analysis of Prostate Cancer Vaccine
9.1 Marketing Channels Status of Prostate Cancer Vaccine
9.2 Traders or Distributors of Prostate Cancer Vaccine with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Prostate Cancer Vaccine
9.4 United States Import, Export and Trade Analysis of Prostate Cancer Vaccine
10 Development Trend of Prostate Cancer Vaccine Industry 2016-2021
10.1 Capacity and Production Overview of Prostate Cancer Vaccine 2016-2021
10.2 Production Market Share by Product Types of Prostate Cancer Vaccine 2016-2021
10.3 Sales and Sales Revenue Overview of Prostate Cancer Vaccine 2016-2021
10.4 United States Sales of Prostate Cancer Vaccine by Applications 2016-2021
10.5 Import, Export and Consumption of Prostate Cancer Vaccine 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Prostate Cancer Vaccine 2016-2021
11 Industry Chain Suppliers of Prostate Cancer Vaccine with Contact Information
11.1 Major Raw Materials Suppliers of Prostate Cancer Vaccine with Contact Information
11.2 Manufacturing Equipment Suppliers of Prostate Cancer Vaccine with Contact Information
11.3 Major Players of Prostate Cancer Vaccine with Contact Information
11.4 Key Consumers of Prostate Cancer Vaccine with Contact Information
11.5 Supply Chain Relationship Analysis of Prostate Cancer Vaccine
12 New Project Investment Feasibility Analysis of Prostate Cancer Vaccine
12.1 New Project SWOT Analysis of Prostate Cancer Vaccine
12.2 New Project Investment Feasibility Analysis of Prostate Cancer Vaccine
13 Conclusion of the United States Prostate Cancer Vaccine Industry 2016 Market Research Report
Figure Picture of Prostate Cancer Vaccine
Table Product Specifications of Prostate Cancer Vaccine
Table Classification of Prostate Cancer Vaccine
Figure United States Sales Market Share of Prostate Cancer Vaccine by Product Types in 2015
Table Applications of Prostate Cancer Vaccine
Figure United States Sales Market Share of Prostate Cancer Vaccine by Applications in 2015
Figure Industry Chain Structure of Prostate Cancer Vaccine
Table United States Industry Overview of Prostate Cancer Vaccine
Table Industry Policy of Prostate Cancer Vaccine
Table Industry News List of Prostate Cancer Vaccine
Table Bill of Materials (BOM)of Prostate Cancer Vaccine
Table Bill of Materials (BOM)Price of Prostate Cancer Vaccine
Table Labor Cost of Prostate Cancer Vaccine
Table Depreciation Cost of Prostate Cancer Vaccine
Table Manufacturing Cost Structure Analysis of Prostate Cancer Vaccine in 2015
Figure Manufacturing Process Analysis of Prostate Cancer Vaccine
Table United States Price Analysis of Prostate Cancer Vaccine 2011-2016 (USD/Dose)
Table United States Cost Analysis of Prostate Cancer Vaccine 2011-2016 (USD/Dose)
Table United States Gross Analysis of Prostate Cancer Vaccine 2011-2016
Table Capacity (K Dose)and Commercial Production Date of United States Prostate Cancer Vaccine Key Manufacturers in 2015
Table Manufacturing Plants Distribution of United States Key Prostate Cancer Vaccine Manufacturers in 2015
Table R&D Status and Technology Source of United States Prostate Cancer Vaccine Key Manufacturers in 2015
Table Raw Materials Sources Analysis of United States and United States Prostate Cancer Vaccine Key Manufacturers in 2015
Table United States Production of Prostate Cancer Vaccine by Regions 2011-2016 (K Dose)
Table United States Production Market Share of Prostate Cancer Vaccine by Regions 2011-2016
Figure United States Production Market Share of Prostate Cancer Vaccine by Regions in 2014
Figure United States Production Market Share of Prostate Cancer Vaccine by Regions in 2015
Table United States Production of Prostate Cancer Vaccine by Types in 2011-2016 (K Dose)
Table United States Production Market Share of Prostate Cancer Vaccine by Type in 2011-2016
Figure United States Production Market Share of Prostate Cancer Vaccine by Type in 2014
Figure United States Production Market Share of Prostate Cancer Vaccine by Type in 2015
Table United States Sales of Prostate Cancer Vaccine by Applications 2011-2016 (K Dose)
Table United States Production Market Share of Prostate Cancer Vaccine by Applications 2011-2016
Figure United States Production Market Share of Prostate Cancer Vaccine by Applications in 2014
Figure United States Production Market Share of Prostate Cancer Vaccine by Applications in 2015
Table Price Comparison of United States Prostate Cancer Vaccine Key Manufacturers in 2015 (USD/Dose)
Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD)of Prostate Cancer Vaccine 2011-2016
Table United States Consumption Volume of Prostate Cancer Vaccine by Regions 2011-2016 (K Dose)
Table United States Consumption Volume Market Share of Prostate Cancer Vaccine by Regions 2011-2016
Figure United States Consumption Volume Market Share of Prostate Cancer Vaccine by Regions in 2014
Figure United States Consumption Volume Market Share of Prostate Cancer Vaccine by Regions in 2015
Table United States Consumption Value of Prostate Cancer Vaccine by Regions 2011-2016 (M USD)
Table United States Consumption Value Market Share of Prostate Cancer Vaccine by Regions 2011-2016
Figure United States Consumption Value Market Share of Prostate Cancer Vaccine by Regions in 2014
Figure United States Consumption Value Market Share of Prostate Cancer Vaccine by Regions in 2015
Table Consumption Price of Prostate Cancer Vaccine by Regions 2011-2016 (USD/Dose)
Table United States and Major Manufacturers Capacity of Prostate Cancer Vaccine 2011-2016 (K Dose)
Table United States Capacity Market Share of Major Prostate Cancer Vaccine Manufacturers 2011-2016
Table United States and Major Manufacturers Production of Prostate Cancer Vaccine 2011-2016 (K Dose)
Table United States Production Market Share of Major Prostate Cancer Vaccine Manufacturers 2011-2016
Table United States and Major Manufacturers Sales of Prostate Cancer Vaccine 2011-2016 (K Dose)
Table United States Sales Market Share of Major Prostate Cancer Vaccine Manufacturers 2011-2016
Table United States and Major Manufacturers Sales Revenue of Prostate Cancer Vaccine 2011-2016 (M USD)
Table United States Sales Revenue Market Share of Major Prostate Cancer Vaccine Manufacturers 2011-2016
Figure United States Capacity (K Dose), Production (K Dose)and Growth Rate of Prostate Cancer Vaccine 2011-2016
Figure United States Capacity Utilization Rate of Prostate Cancer Vaccine 2011-2016
Figure United States Sales Revenue (M USD)and Growth Rate of Prostate Cancer Vaccine 2011-2016
Figure United States Production Market Share of Major Prostate Cancer Vaccine Manufacturers in 2014
Figure United States Production Market Share of Major Prostate Cancer Vaccine Manufacturers in 2015
Figure United States Sales Market Share of Major Prostate Cancer Vaccine Manufacturers in 2014
Figure United States Sales Market Share of Major Prostate Cancer Vaccine Manufacturers in 2015
Figure United States Sales (K Dose)and Growth Rate of Prostate Cancer Vaccine 2011-2016
Table United States Supply, Consumption and Gap of Prostate Cancer Vaccine 2011-2016 (K Dose)
Table United States Import, Export and Consumption of Prostate Cancer Vaccine 2011-2016 (K Dose)
Table Price of United States Prostate Cancer Vaccine Major Manufacturers 2011-2016 (USD/Dose)
Table Gross Margin of United States Prostate Cancer Vaccine Major Manufacturers 2011-2016
Table United States and Major Manufacturers Revenue of Prostate Cancer Vaccine 2011-2016 (M USD)
Table United States Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD)and Gross Margin of Prostate Cancer Vaccine 2011-2016
Table Bellicum pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Prostate Cancer Vaccine Picture and Specifications of Bellicum pharmaceuticals
Table Prostate Cancer Vaccine Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD)and Gross Margin of Bellicum pharmaceuticals 2011-2016
Figure Prostate Cancer Vaccine Capacity (K Dose), Production (K Dose)and Growth Rate of Bellicum pharmaceuticals 2011-2016
Figure Prostate Cancer Vaccine Production (K Dose)and United States Market Share of Bellicum pharmaceuticals 2011-2016
Table Bellicum pharmaceuticals Prostate Cancer Vaccine SWOT Analysis
Table Adamis pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Prostate Cancer Vaccine Picture and Specifications of Adamis pharmaceuticals
Table Prostate Cancer Vaccine Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD)and Gross Margin of Adamis pharmaceuticals 2011-2016
Figure Prostate Cancer Vaccine Capacity (K Dose), Production (K Dose)and Growth Rate of Adamis pharmaceuticals 2011-2016
Figure Prostate Cancer Vaccine Production (K Dose)and United States Market Share of Adamis pharmaceuticals 2011-2016
Table Adamis pharmaceuticals Prostate Cancer Vaccine SWOT Analysis
Table Aduro biotech Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Prostate Cancer Vaccine Picture and Specifications of Aduro biotech
Table Prostate Cancer Vaccine Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD)and Gross Margin of Aduro biotech 2011-2016
Figure Prostate Cancer Vaccine Capacity (K Dose), Production (K Dose)and Growth Rate of Aduro biotech 2011-2016
Figure Prostate Cancer Vaccine Production (K Dose)and United States Market Share of Aduro biotech 2011-2016
Table Aduro biotech Prostate Cancer Vaccine SWOT Analysis
Table Cytovac Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Prostate Cancer Vaccine Picture and Specifications of Cytovac
Table Prostate Cancer Vaccine Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD)and Gross Margin of Cytovac 2011-2016
Figure Prostate Cancer Vaccine Capacity (K Dose), Production (K Dose)and Growth Rate of Cytovac 2011-2016
Figure Prostate Cancer Vaccine Production (K Dose)and United States Market Share of Cytovac 2011-2016
Table Cytovac Prostate Cancer Vaccine SWOT Analysis
Table Immunovaccine Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Prostate Cancer Vaccine Picture and Specifications of Immunovaccine
Table Prostate Cancer Vaccine Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD)and Gross Margin of Immunovaccine 2011-2016
Figure Prostate Cancer Vaccine Capacity (K Dose), Production (K Dose)and Growth Rate of Immunovaccine 2011-2016
Figure Prostate Cancer Vaccine Production (K Dose)and United States Market Share of Immunovaccine 2011-2016
Table Immunovaccine Prostate Cancer Vaccine SWOT Analysis
Table Oncbiomune Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Prostate Cancer Vaccine Picture and Specifications of Oncbiomune
Table Prostate Cancer Vaccine Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD)and Gross Margin of Oncbiomune 2011-2016
Figure Prostate Cancer Vaccine Capacity (K Dose), Production (K Dose)and Growth Rate of Oncbiomune 2011-2016
Figure Prostate Cancer Vaccine Production (K Dose)and United States Market Share of Oncbiomune 2011-2016
Table Oncbiomune Prostate Cancer Vaccine SWOT Analysis
Table Dendreon Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Prostate Cancer Vaccine Picture and Specifications of Dendreon
Table Prostate Cancer Vaccine Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD)and Gross Margin of Dendreon 2011-2016
Figure Prostate Cancer Vaccine Capacity (K Dose), Production (K Dose)and Growth Rate of Dendreon 2011-2016
Figure Prostate Cancer Vaccine Production (K Dose)and United States Market Share of Dendreon 2011-2016
Table Dendreon Prostate Cancer Vaccine SWOT Analysis
Table Sotio Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Prostate Cancer Vaccine Picture and Specifications of Sotio
Table Prostate Cancer Vaccine Capacity (K Dose), Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD)and Gross Margin of Sotio 2011-2016
Figure Prostate Cancer Vaccine Capacity (K Dose), Production (K Dose)and Growth Rate of Sotio 2011-2016
Figure Prostate Cancer Vaccine Production (K Dose)and United States Market Share of Sotio 2011-2016
Table Sotio Prostate Cancer Vaccine SWOT Analysis
Table Prostate Cancer Vaccine Price by Regions 2011-2016
Table Prostate Cancer Vaccine Price by Product Types 2011-2016
Table Prostate Cancer Vaccine Price by Companies 2011-2016
Table Prostate Cancer Vaccine Gross Margin by Companies 2011-2016
Table Price Comparison of Prostate Cancer Vaccine by Regions 2011-2016 (USD/Dose)
Table Price of Different Prostate Cancer Vaccine Product Types (USD/Dose)
Table Market Share of Different Prostate Cancer Vaccine Price Level
Table Gross Margin of Different Prostate Cancer Vaccine Applications
Table Marketing Channels Status of Prostate Cancer Vaccine
Table Traders or Distributors of Prostate Cancer Vaccine with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Prostate Cancer Vaccine (USD/Dose)in 2015
Table United States Import, Export, and Trade of Prostate Cancer Vaccine (K Dose)
Figure United States Capacity (K Dose), Production (K Dose)and Growth Rate of Prostate Cancer Vaccine 2016-2021
Figure United States Capacity Utilization Rate of Prostate Cancer Vaccine 2016-2021
Table United States Prostate Cancer Vaccine Production by Type 2016-2021 (K Dose)
Table United States Prostate Cancer Vaccine Production Market Share by Type 2016-2021
Figure United States Production Market Share of Prostate Cancer Vaccine by Type in 2021
Figure United States Sales (K Dose)and Growth Rate of Prostate Cancer Vaccine 2016-2021
Figure United States Sales Revenue (Million USD)and Growth Rate of Prostate Cancer Vaccine 2016-2021
Figure United States Sales of Prostate Cancer Vaccine by Applications 2016-2021 (K Dose)
Table United States Production Market Share of Prostate Cancer Vaccine by Applications 2016-2021
Figure United States Production Market Share of Prostate Cancer Vaccine by Applications in 2021
Table United States Production, Import, Export and Consumption of Prostate Cancer Vaccine 2016-2021 (K Dose)
Table United States Production (K Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD)and Gross Margin of Prostate Cancer Vaccine 2016-2021
Table Major Raw Materials Suppliers of Prostate Cancer Vaccine with Contact Information
Table Manufacturing Equipment Suppliers of Prostate Cancer Vaccine with Contact Information
Table Major Players of Prostate Cancer Vaccine with Contact Information
Table Key Consumers of Prostate Cancer Vaccine with Contact Information
Table Supply Chain Relationship Analysis of Prostate Cancer Vaccine
Table New Project SWOT Analysis of Prostate Cancer Vaccine
Table New Project Investment Feasibility Analysis of Prostate Cancer Vaccine
Table Part of Interviewees Record List
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
